Quality of life and functional improvements with the IL-6 receptor inhibitor tocilizumab in patients with active rheumatoid arthritis despite DMARD therapy: The toward study Annual Meeting of the British-Society-Rheumatology/Spring Meeting of British Health Professional in Rheumatology Gomez-Reino, J. J., FAIRFAX, M. J., Pavelka, K., Alecock, E., Woodworth, T., Laughton, J., Eves, D., Genovese, M. C. OXFORD UNIV PRESS. 2008: II49–II49

View details for Web of Science ID 000254680900164